Publication Title The Issue The Author
Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ
Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility
Almac Rewarded for Excellence in Technology
Almac reports progress in Clinical Technologies Lean Six Sigma Efforts
Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array
Almac’s Clinical Trial Workshop Series to return in 2012
Almac and SRC to boost training for science careers
Almac adds aXcess™ to its suite of services to complement clinical packaging and distribution bundle
Almac expands in US with addition of Commercial Packaging facility in Audubon, PA.
Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment
selectAZyme™ grows into metabolite synthesis
One Year On…Almac Doubles Analytical Capacity in US Headquarters
Almac announce launch of Next Generation Sequencing (NGS) Data Analysis Services
Almac Celebrates MHRA Audit Successes
MGB Biopharma and Almac Collaborate on Contract Manufacturing Project
Almac strengthens Board with appointment of new Financial Director
New building will help Almac serve customers from Argentina to Zimbabwe
Almac’s New Clinical Supply Forecasting Tool – COMPASS – To Improve Clinical Trial Management
Almac’s Diagnostic Laboratory Receives Accreditation from College of American Pathologists
Almac extends helping hand to local charities
Almac Shines At Awards Ceremonies
Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany
Co Tyrone woman is Almac’s 2,000th UK employee
Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology
Almac’s rapidd continuing to accelerate early stage development 2 years on…
Almac Invests in New Commercial API Manufacturing
Almac Invests £1M in Dedicated Mass Spectrometry Laboratory
Almac Announces Expansion of Pharmaceutical Development Facilities
Almac and Greenphire Form Alliance to Deliver Direct-to-Patient Stipend Payments Through IXRS®
Almac flies the flag for European Day of Languages
Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion
Almac-Queen’s cancer expert to lead £4.4m collaboration
Almac wins ‘The American Society for Quality’ Award in Philadelphia
Almac to perform the analytic phase of AclarusDx™ for Exonhit
Almac Expands Global Coverage by Adding Depots for Clinical Trial Supply Distribution to the Asia Pacific Region
Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago
Almac data to be presented at annual ASCO meeting
Almac celebrate official opening of North American HQ with former US. Senator George Mitchell
Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies
Todd Kole Appointed to Almac’s Clinical Technologies Executive Team
Almac Introduces selectAZymeTM
Almac wins 2011 Northern Ireland Business of the year accolade
Northgate Managed Services Delivers Seamless Transfer to Almac’s New US HQ
Almac open CLIA lab for biomarker clinical trials
BioFocus and Almac collaborate to offer fluorescent lifetime assays
Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products
Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences
Almac and Exco InTouch Form Alliance to Deliver Patient Compliance and ePRO Services Using Multiple Technologies
The A to ZED of Automated Walleting for clinical trial supply
Live Webinar March 28th: An Integrated Approach to Biomarker Discovery
Almacs New Headquarters Takes Control of Scheduled I-V Substances Capabilities
Almac announce Launch of Bioinformatics Consultancy
Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
Almac Opens Analytical Labs in New US Headquarters
Distribution Heats Up as Almac Continues its Transition to New North American Headquarters
Almac wins News Flow of the Year Category at the Genesis 2010 Awards
Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe
Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com
Almac and the Royal Society of Chemistry host a workshop on the use of analytical techniques to control and monitor solid form
Almacs Clinical Technologies Business Unit Again Receives `Best Places to Work in PA 2010′ Award
Almac has Successful MHRA Inspection at its Clinical Services UK Site
Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters
Almac continues biocatalysis business growth with a further $4m R&D investment
Almac ‘Event in the Tent’ raises £14,500 for Charities
Almacs North American Headquarters Opens Its Doors for Audits
Almacs Clinical Technologies Division undergoes successful joint GCP-GMP MHRA Inspection
Almac One Step Closer to Completion of U.S. Headquarters Buildings
View our Client Message Regarding New North American Headquarters
Almac Discusses New Biomarker Service on OutsourcingPharma.com
Almac launch Biomarkers for biopharma
Bill Kane Joins Almac as Director of Quality Assurance and Regulatory Compliance
Almac supports Queens University “oncology hub” with new McClay library
Almac Announces Collaboration with Aeterna Zentaris to Develop Therapy and Companion Diagnostic in Cancer
Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of Almac
Almac’s US Headquarters will Address Capacity Demand for Clinical Supplies
Almac completes £2 million client sponsored investment expanding commercial sacheting capacity
Almac to feature Expert Speakers at Upcoming DIA Annual Meeting
Almac Announces Launch of IXRS® 2.0 Next Generation Clinical Technology
Almac Launch Xcel Array – the Optimum Platform for Biomarker Discovery
Almac wins UK Great Place to Work award
Almac and University College Cork announce launch of academic/industrial collaboration in the field of solid state chemistry
Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials
Almac extends Site-specific PEGylation Technology to single domain antibodies
Almac Announces Environmentally-Friendly Features
Graham Nicholls Joins Almac as Director of Biostatistics
Almac completes its expansion plan to Pharma Services facilities
Almac completes its expansion plan to Pharma Services facilities
Almac Group Finds Pharmony With New Website
Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy
Almac Clinical Technologies Releases Almac Interactive Reporting for IXRS
Almac wins Excellence in Innovation Category at the Tenth Annual Belfast Telegraph / BMI Northern Ireland Business Awards
New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing
Almac to Improve Label Approval Process in Clinical Trials
Almac and Queens University Belfast showcase Northern Irish ‘oncology hub’ to senior Washington DC delegates
Almac wins prestigious Aer Lingus Viscount Award for Overall Excellence
Successful Inspection by FDA of Almac Clinical Services North Carolina Facility
Almac Expands Radiolabelling Facilities to Include 14C API and IMP Supply
Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities
Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays
Statement on the Sad Death of Sir Allen McClay
Almac Clinical Technologies Announces Patient-Reported-Outcomes Partnership with FACIT.org
Bioinformatics Expansion Heralds Further Growth for Almac
Almac Doubles Capacity at North Carolina Facility
Almac to Speak at Upcoming CDISC Interchange with Technology Partners
Almac Launches Unique Site-specific PEGylation Technology at BIO Europe
Almac Announce Potent Containment Capabilities
Almac Extends Commercial Support Services to add Third Party Logistics “3PL”
“rapidd” Accelerating Early Stage Development, Minimising Cash Burn
US Labs will Extend Analytical and Solid State Support
Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec
Almac staff raise £9,000 for local charities
Almac Clinical Technologies Named One of the ‘Best Places to Work in PA 2009′
Almac Secures Room to Grow; Plans Expected to Lead to 500 Jobs
Almac and Lilly Partner on Companion Diagnostic Development
Establishment of McClay Foundation Marks New Era for Northern Ireland
UM Breast Cancer Researchers partner with Almac to win prestigious Department of Defense Grant
MHRA Grants Almac IMP License for its Radiolabelling Service
Almac Group Continues Aggressive Hiring Campaign in PA to Meet Growing Demand from Pharma and Biotech Customers
Official opening of Almac Diagnostics headquarters
Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities
Pennsylvania Governor Edward G. Rendell visits Almac
Almac to Showcase Integrated Clinical Trial Solutions at 45th Annual DIA Meeting
Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules
Almac Announces Collaboration with Pfizer and the PETACC3 Translational Research Working Party
Almac Event Proves Engineers Make It Happen
Dr Tanney Discusses Challenges Faced in Fine Tuning Sample Preparation Techniques
Minister Praises Craigavon Life Sciences Firm’s Commitment To Research and Development
Almac Launches Biocatalyst Kits
Almac and PHT Announce Formal Alliance to Improve Clinical Trial Data Quality
Almac – `Business of the Year Award is Company Milestone’
Almac Group Uses HP Technology to Bring New Drugs to Market Faster
Almac Showcases ePRO Technology at 21st DIA EuroMeeting
Almac Tops Off New North American Headquarters
Almac Collect Top Recognition for New Ovarian Cancer Research Product
Almac Win “Exporter of the Year” in Economic Awards
Almac Completes First Paperless Client Audit
Almac Continues Global Expansion of Clinical Supply Services with Huge Facility for Specialist Storage
Almac Jobs Boost for Northern Ireland
Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG
Almac Promotes Biocatalysis and Radiolabeling
Almac Launches Solid State Services
Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
Key Almac division celebrates 20 years of growth
Almac Selects NuGEN Ovation® Systems to Broaden Gene Expression
Almac Clinical Technologies Expands Yardley, PA Headquarters
Almac Growth Continues Into 2009
Almac Clinical Services milestone achievement as full GMP compliance achieved across global sites
Almac addresses leading cancer specialists at All-Ireland conference
Almac Clinical Services Craigavon Facility Achieves Successful Inspection by MHRA
Almac Group Staff Raise £7,000 for Local Charities
Successful inspection by MHRA of Almac Clinical Services’ Pennsylvanian facility
“Real potential of clinical technologies yet to be realized” says Almac
Almac Diagnostics Launches Ovarian Cancer Research Tool
Almac Donate $50,000 to Harleysville Area Emergency Medical Services
Almac Announce World’s Largest Gene Expression Study To Develop Prognostic Test for Early Non Small Cell Lung Cancer
Governor Rendell and Sir Allen McClay break ground at site of new Almac North American headquarters
Almac Testers Receive ISTQB Software Testing Certification
Almac Diagnostics Join Personalized Medicine Coalition
Almac Group Launches Oncology Discovery Arm
Almac Clinical Technologies signs contracts for a number of large, complex Clinical Trials
WebEZ™ reaches a key milestone
Almac Diagnostics in new deal to provide unique process to extract genetic information from Clinical Trial samples
Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond
Almac Pharma Services Expands it Commercial Support Capability
Almac appoints new VP Commercial Operations for Pharma Services
Almac Inks 15-Year Deal with Affy to Secure 
Rights to Develop and Sell Array-Based Dxs
The Power of Communication
Almac Diagnostics Extends Agreement with Affymetrix
Almac Expands Express Suite at DIA EuroMeeting
Largest Ever Clinical Trials Cargo Shipped from Northern Ireland
Almac: more US connections
Almac & Merck to Present Adaptive Case Study at Upcoming Conference
Almac wins top award at Tech Idol Showcase
Almac Sciences: a global supply chain approach
Almac Sciences: “First in man” approach to peptides
Almac at the centre of industry thinking
BRCA1 Mutations Influence Cancer Cells’ Response to Drugs
Sophogen appoints Almac Diagnostics as Service Provider to offer Personalized Genotyping Services
Almac to Build New US American Headquarters
Almac Teams up with the Leukemia and Lymphoma Society
Northern Ireland First Minister Commends Almac As a World Class Pharmaceutical Organisation
Almac Clinical Technologies Hires New Director in San Francisco Office
Recent Survey Results Praise Customer Service
Almac’s Web Drug Reconciliation tool named finalist in GCPj awards
Top of the Class for Almac Fundraisers
Almac Diagnostics Announces Pioneering Genetic Research on Ductal Carcinoma In Situ (DCIS) Using Breast Cancer DSA™ Research Tool
Sir Allen Interview Features in Belfast Telegraph’s “The Monday Interview”
Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process
Almac present on Investigational Medicinal Products to leading Industry body
Almac Clinical Services Feature in “The Big Question”
Almac Group Highly Commended at NI Workplace and Employment Awards
Almac Clinical Services to present at FDA Symposium at Harvard University.
Almac Diagnostics Attends Pre-ide Meeting With FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue Craigavon, Northern Ireland, 28 May 2007
Prof Patrick Johnston of Queen’s University Belfast & Almac Diagnostics honoured by President McAleese
Almac Clinical Technologies speaks on ‘Quality’ at 43rd DIA Annual Meeting
Latest iTrial EDC includes new PDF Audit Trail function
Almac Launches New Innovative Clinical Supply Systems
Almac Hosts Successful Clinical Supply Management Workshops across North America
`Increase Role of Science in Schools’ says Almac Chairman
Almac Diagnostics Announces Pioneering Genetic Research
Sir Allen McClay: “Almac Leading The Way In Global Pharmaceutical Development”
Almac Sciences Feature in “What Job Do You Do?”
Almac Clinical Technologies At Top Clinical Trial Conferences
Almac Sciences Invest In Edinburgh Facility
Almac visit QUB to brief Pharmacists
SafeBridge® Certification for Almac Sciences’ cytotoxics plant
Almac Sciences and BioCatalytics Inc. to 
co-operate on key pharma products
CPST fill-and-finish agreement for Almac Sciences’ cytotoxics
Almac Clinical Technologies Appoints New Director of Business Development
Almac distribution network now worldwide
Almac Recruits Additional 250 Employees in NI in 2006
Almac Clinical Technologies Spreading Holiday Cheer
Diagnostics Multi Year License Agreement With GeneGo
Almac Scoops Top UK Training Award
Clinical Technologies Expands Its European Operations
Almac Clinical Services Celebrates 10 Years in US
Almac Pharma Services Extend Formulation Facilities
Almac Hosts Science Development Day for Colleges
Almac Clinical Services Scoops National Training Award
Almac Sciences Scales Up for Peptides
Almac Staff Raise Funds For Northern Ireland Charities
Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool
Clinical Services Continues Expansion with New Refrigerated Facility
Clinical Services Expands Its Global Depot Network
Pharma Companies Combine Under Almac Banner
CTS Awarded Best Classroom Training Manual at 2006 PDA Biennial Training Conference
ICTI Announces New President
CTS Durham Undergoes EU-GMP Inspection From MHRA
ICTI to Speak on Adaptive Trial Design at Brussels Conference
CTS Host Successful Global Clinical Trial Distribution Workshops In The US
Health Minister Visits Almac Sciences Facility
ICTI Presents at DIAs 21st Clinical Data Management Symposium
ICTI Implements Latest Version of MasterControl Training
Almac Helps Governor Take Temperature Of NI Economy
World Renown Cancer Specialists Visit Almac Sciences
PDMS Extend Formulation Development Facility
Eirx Therapeutic Plc & Diagnostics Agreement
CSS Radio Goes Live; Chiral Building Blocks Range Announced
Sir Allen McClay Opens New £1.25 million Laboratory of Biology Chemistry at Queens
CTS Announce Agenda for Clinical Trial Distribution Workshops
ICTI Biostatistics Expert speaks at International Conference
Almac Diagnostics Receives ISO17025 Accreditation
ICTI Expands European Operations
ArraDx Joins Almac Sciences – Now Almac Diagnostics
Dr Allen McClay, CBE Receives Knighthood in New Year’s Honours List
ICTI Completes Implementation of Tech-Support Software: IncidentMonitor TM
CSS Focuses on Australian Market
CSS Launches Global Provision of Radiolabelling Services
ICTI software used in major Government Study
ICTI Expert Hosts Roundtable at FDA Conference
ICTI Biostatistics Expert speaks at International Conference
ICTI Increase Drug Study Management Efficiency
PDMS Awards Major Pharmaceuticals Manufacturing System Contract to SSI
ICTI Announce Successful Implementation of a SAN
ICTI Marks Milestone for EDC
ICTI Acquires Leading EDC Software
CSS Albachem Secures a Share of £3.7 million R&D Programme
Chiral Consortium
CSS Enters Chiral Market Through Collaborations with ChiralQuest and IEP
CSS Expands Capability in Specialist Manufacturing
CSS Launches Unique Consortium at CPhI
Company Name Change
CSS Acquires Controlling Interest in Peptide Company ALBACHEM
Almac Sciences acquire PDMS
Senator GEORGE MITCHELL Officially Opens New CSS Facility

print

Flash replacement image